New Appointment to the Advisory Board - Dr Qiusong Tang

HKLSS is pleased to announce the appointment of Dr Qiusong Tang, Global Search & Evaluation Lead, Immunology, Infectious Diseases, Cardiovascular, Renal and Metabolic Disease, Corporate Business Development, Genentech (a member of the Roche Group), as a member of the Advisory Board, effective 1 January 2026. Based in San Francisco, his strategic insights, broad ecosystem networks, and cross-regional experience in research, strategy consulting, and external innovation will support HKLSS’s mission in life sciences and technology.